Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The 13 mg blend (10 mg Tesamorelin + 3 mg Ipamorelin) is intended as a comparative pharmacology research blend for investigators studying paired GHRH and GHS-R pathway signaling in preclinical models of body composition, growth hormone dynamics, and metabolic endpoints
Sourcing considerations GHK-Cu is sold lyophilized and in blends (for example with BPC-157 and TB-500 in "GLOW"-style formulas)
Custom Compounding Fast Turnaround Were pursuing better to help others : Our Products Redefining quality Were committed to the science, processes, and technology that allow us to adhere to the highest standards and produce the best outcomes for the patients our providers serve
Patients with significant pituitary disease, uncontrolled diabetes, or severe cardiovascular disease should not pursue Sermorelin without specialist supervision
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of [PMID: 10195374] Laboratory literature summary: Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in research subjects
Genetics tells you why a lab value might be trending a certain way
US$ 23.63
US$ 28.77
US$ 25.76
